- Home
- CSTE vs CLLS Comparison
CSTE vs CLLS Comparison
Compare CSTE & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- CLLS
- Stock Information
- Founded
- CSTE 1987
- CLLS 1999
- Country
- CSTE Israel
- CLLS France
- Employees
- CSTE N/A
- CLLS N/A
- Industry
- CSTE Building Materials
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- CSTE Industrials
- CLLS Health Care
- Exchange
- CSTE Nasdaq
- CLLS Nasdaq
- Market Cap
- CSTE 131.2M
- CLLS 148.1M
- IPO Year
- CSTE 2012
- CLLS 2007
- Fundamental
- Price
- CSTE $3.80
- CLLS $1.53
- Analyst Decision
- CSTE Strong Buy
- CLLS Buy
- Analyst Count
- CSTE 1
- CLLS 3
- Target Price
- CSTE $6.00
- CLLS $7.00
- AVG Volume (30 Days)
- CSTE 29.6K
- CLLS 114.3K
- Earning Date
- CSTE 03-05-2025
- CLLS 11-04-2024
- Dividend Yield
- CSTE N/A
- CLLS N/A
- EPS Growth
- CSTE N/A
- CLLS N/A
- EPS
- CSTE N/A
- CLLS N/A
- Revenue
- CSTE $473,883,000.00
- CLLS $36,042,000.00
- Revenue This Year
- CSTE N/A
- CLLS $387.77
- Revenue Next Year
- CSTE $2.64
- CLLS $11.14
- P/E Ratio
- CSTE N/A
- CLLS N/A
- Revenue Growth
- CSTE N/A
- CLLS 46.96
- 52 Week Low
- CSTE $3.76
- CLLS $1.41
- 52 Week High
- CSTE $6.81
- CLLS $3.38
- Technical
- Relative Strength Index (RSI)
- CSTE 35.81
- CLLS 45.06
- Support Level
- CSTE $3.94
- CLLS $1.51
- Resistance Level
- CSTE $4.15
- CLLS $1.62
- Average True Range (ATR)
- CSTE 0.20
- CLLS 0.09
- MACD
- CSTE -0.05
- CLLS 0.01
- Stochastic Oscillator
- CSTE 0.00
- CLLS 29.17
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.